Clarion Hospital
Clarion Hospital was paid $2.09M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
CLARION, PA 16214
Next to other Clinic/Center providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48 | $6K | |
| 2019 | 85 | $579.78 | |
| 2020 | 12,721 | $236K | |
| 2021 | 45,149 | $1.00M | |
| 2022 | 10,387 | $196K | |
| 2023 | 13,142 | $227K | |
| 2024incomplete | 10,887 | $419K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 4,222 | 4,009 | $422K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 10% | 5,947 | 1,562 | $217K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.7% | 6,462 | 6,253 | $202K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.0% | 1,948 | 1,837 | $126K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.4% | 1,242 | 1,178 | $91K |
| 80053 | Comprehensive metabolic panel | 4.4% | 9,824 | 8,504 | $91K |
| G0378 | Hospital observation service, per hour | 3.4% | 301 | 217 | $70K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.0% | 548 | 521 | $63K |
| 80050 | General health panel | 2.6% | 1,203 | 1,159 | $54K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 2,014 | 1,919 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 10,600 | 9,076 | $50K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 1,312 | 1,254 | $46K |
155 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 1,199 | $36K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 453 | $36K |
| 80061 | Lipid panel | 1.4% | 2,244 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 426 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 3,049 | $24K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 1,223 | $23K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 91 | $23K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 141 | $21K |
| 87428 | <1% | 655 | $19K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,079 | $17K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 294 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 257 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 862 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 730 | $14K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 641 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 368 | $13K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 212 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,218 | $12K |
| 81001 | <1% | 4,219 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,514 | $10K |
| 97161 | <1% | 233 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 450 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 120 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 698 | $9K |
| 0001A | <1% | 299 | $8K | |
| 0002A | <1% | 199 | $8K | |
| 84484 | <1% | 1,044 | $7K | |
| 87480 | <1% | 270 | $6K | |
| 83735 | <1% | 968 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 499 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 850 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 708 | $6K |
| 86618 | <1% | 168 | $5K | |
| 87660 | <1% | 266 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 679 | $4K |
| 84439 | <1% | 482 | $4K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 90 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 161 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 161 | $4K |
| 87486 | <1% | 92 | $3K | |
| 83690 | <1% | 816 | $3K | |
| 87510 | <1% | 211 | $3K | |
| 82728 | <1% | 287 | $3K | |
| 80305 | <1% | 304 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 45 | $3K |
| 87490 | <1% | 125 | $3K | |
| 83540 | <1% | 317 | $2K | |
| 87186 | <1% | 321 | $2K | |
| 85027 | <1% | 402 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 94 | $2K |
| 83605 | <1% | 408 | $2K | |
| 84702 | <1% | 141 | $2K | |
| 73564 | <1% | 108 | $2K | |
| 82043 | <1% | 272 | $2K | |
| 82607 | <1% | 167 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 21 | $2K |
| 87631 | <1% | 12 | $2K | |
| 82553 | <1% | 280 | $2K | |
| 82550 | <1% | 370 | $2K | |
| 0003A | <1% | 44 | $2K | |
| 73610 | <1% | 103 | $2K | |
| 0011A | <1% | 39 | $2K | |
| 93971 | <1% | 28 | $2K | |
| 73030 | <1% | 102 | $2K | |
| 73630 | <1% | 153 | $1K | |
| 87040 | <1% | 92 | $1K | |
| 83655 | <1% | 131 | $1K | |
| 84703 | <1% | 134 | $1K | |
| 96523 | <1% | 110 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 48 | $1K |
| 87797 | <1% | 61 | $1K | |
| 88164 | <1% | 172 | $1K | |
| 82570 | <1% | 103 | $1K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $1K |
| 82248 | <1% | 170 | $1K | |
| 73130 | <1% | 95 | $1K | |
| 0012A | <1% | 24 | $1K | |
| 87070 | <1% | 165 | $1K | |
| 87088 | <1% | 156 | $1K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 537 | $1K |
| 82565 | <1% | 167 | $946.29 | |
| 83880 | <1% | 59 | $918.06 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 965 | $866.84 |
| 86140 | <1% | 296 | $844.87 | |
| 82150 | <1% | 198 | $843.00 | |
| 85652 | <1% | 265 | $748.19 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,412 | $738.43 |
| 83550 | <1% | 163 | $723.14 | |
| 72110 | <1% | 41 | $698.07 | |
| 81025 | <1% | 170 | $644.51 | |
| 85610 | <1% | 287 | $626.86 | |
| 0072A | <1% | 14 | $616.00 | |
| 80076 | <1% | 68 | $583.21 | |
| 84146 | <1% | 25 | $528.00 | |
| 87077 | <1% | 77 | $476.55 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 16 | $448.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 58 | $443.07 |
| 85007 | <1% | 155 | $433.18 | |
| 74018 | <1% | 49 | $430.45 | |
| 85651 | <1% | 142 | $408.00 | |
| 87400 | <1% | 39 | $402.00 | |
| 94761 | <1% | 247 | $399.36 | |
| 85730 | <1% | 75 | $378.49 | |
| 93000 | <1% | 17 | $357.46 | |
| 73110 | <1% | 34 | $354.20 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 394 | $349.94 |
| J3490 | Unclassified drugs | <1% | 206 | $342.76 |
| 84520 | <1% | 72 | $319.77 | |
| 85378 | <1% | 39 | $312.67 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 16 | $292.60 |
| 86803 | <1% | 16 | $288.80 | |
| 84481 | <1% | 14 | $275.29 | |
| 87205 | <1% | 65 | $241.65 | |
| 84460 | <1% | 33 | $238.66 | |
| 84450 | <1% | 33 | $236.24 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 39 | $235.62 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 28 | $227.75 |
| 73502 | <1% | 16 | $194.56 | |
| 87075 | <1% | 12 | $165.00 | |
| 87340 | <1% | 13 | $155.90 | |
| 87081 | <1% | 30 | $154.44 | |
| 87581 | <1% | 50 | $148.58 | |
| 86900 | <1% | 52 | $140.43 | |
| 85379 | <1% | 14 | $139.92 | |
| J2704 | Injection, propofol, 10 mg | <1% | 408 | $134.72 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 104 | $131.17 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 455 | $129.26 |
| 96367 | <1% | 16 | $126.96 | |
| 84100 | <1% | 23 | $115.36 | |
| 81003 | <1% | 38 | $114.15 | |
| 82542 | <1% | 15 | $106.00 | |
| 84550 | <1% | 15 | $102.90 | |
| 87430 | <1% | 12 | $83.16 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 77 | $56.11 |
| 86901 | <1% | 26 | $55.08 | |
| 96376 | <1% | 18 | $43.70 | |
| 86592 | <1% | 12 | $39.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 245 | $36.38 |
| 82948 | <1% | 20 | $32.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 531 | $32.29 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 65 | $31.13 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 300 | $22.88 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 12 | $15.87 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $12.45 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 70 | $11.20 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 389 | $5.19 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $4.74 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 17 | $3.76 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 15 | $0.36 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 12 | $0.16 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 19 | $0.00 |
| A0425 | Ground mileage, per statute mile | 0% | 19 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 66 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 78 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Butler Healthcare Providers | Butler, PA | $10.40M |
| Butler Healthcare Providers | Butler, PA | $1.47M |
| Clarion Hospital EMS | Clarion, PA | $1.01M |
| Butler Memorial Hospital | Butler, PA | $379K |
| Butler Medical Providers | Butler, PA | $345K |
| Butler Medical Providers | Seneca, PA | $208K |
| Butler Medical Providers | Butler, PA | $77K |
| Butler Medical Providers | Butler, PA | $33K |
| Butler Medical Providers | Butler, PA | $32K |
| Butler Medical Providers | New Castle, PA | $32K |
| Butler Medical Providers | Butler, PA | $28K |
| Butler Medical Providers | New Castle, PA | $20K |
| Butler Medical Providers | Slippery Rock, PA | $12K |
| Butler Medical Providers | Butler, PA | $11K |
| Butler Medical Providers | Butler, PA | $11K |
| BHS Faster Care PLLC | Butler, PA | $2K |
| Butler Medical Providers | Fairmount City, PA | $2K |
| Butler Medical Providers | Ford City, PA | $595.87 |
| Butler Medical Providers | Butler, PA | $595.26 |
| Butler Medical Providers | Butler, PA | $486.15 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.